SCHEMBL6288045

SCHEMBL6288045

NC(=O)C[C@@](N)(C(=O)Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@](N)(CC(N)=O)C(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@@](N)(CC(N)=O)C(=O)Cc3c[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 4/20 0.42
HRH3 Q9Y5N1 4/20 0.42
IDO1 P14902 1/20 0.42
MAPT P10636 4/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
GOT1 P17174 4/20 0.41
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
ALOX12 P18054 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PTBP1 P26599 1/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288077 0.90 MAPK8 (0.42) MAPK8L3MBTL1ALDH1A1HRH3IDO1
SCHEMBL6287787 0.90 L3MBTL1 (0.44) MAPK8L3MBTL1ALDH1A1HRH3IDO1
SCHEMBL6287689 0.90 L3MBTL1 (0.44) MAPK8L3MBTL1ALDH1A1HRH3IDO1
SCHEMBL6286770 0.85 GOT1 (0.41) MAPK8L3MBTL1ALDH1A1HRH3IDO1
Hydrochloric Acid SCHEMBL6286771 0.85 MC4R (0.43) MAPK8L3MBTL1ALDH1A1HRH3MAPT
Hydrochloric Acid SCHEMBL6290971 0.85 MC4R (0.43) MAPK8L3MBTL1ALDH1A1HRH3MAPT
Trifluoroacetic Acid SCHEMBL6287929 0.82 MC4R (0.43) L3MBTL1ALDH1A1HRH3MAPTMEN1
SCHEMBL6287427 0.82 MEN1 (0.47) L3MBTL1ALDH1A1HRH3MAPTMEN1
Trifluoroacetic Acid SCHEMBL6290842 0.81 MC3R (0.44) L3MBTL1ALDH1A1HRH3MAPTMEN1
SCHEMBL6290659 0.80 MAPT (0.45) ALDH1A1MAPTKMT2AKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK MAPK8 1669/4885L3MBTL1 1806/4885ALDH1A1 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.